参考文献/References:
[1] Gauberti M,Potzeha F,Vivien D,et al.Impact of bradykinin Generation during thrombolysis in ischemic stroke[J].Fronters in Medicine,2018,5:195.
[2] Trindade AB,Schestatsky P,Torres VF,et al.Functional and regenerative effects of local administration of autologous mononuclear bone marrow cells combined with silicone conduit on transected femoral nerve of rabbits[J].Res Vet Sci,2015,102:27-33.
[3] Jickling GC,Liu DZ,Stamova B,et al.Hemorrhagic transformation after ischemic stroke in animals and humans[J].Journal of Cerebral Blood Flow and Metabolism,2014,34(2):185-199.
[4] Sun MS,Jin H,Sun X,et al.Free radical damage in Ischemia-Reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy[J].Oxid Med Cell Longev,2018,(2):1-17.
[5] Zhu Z,Fu Y,Tian D,et al.Combination of an immune modulator fingolimod with alteplase in acute ischemic stroke:a pilot trial[J].Circulation,2015,132(12):1104-1112.
[6] Sifat AE,Vaidya B,Abbruscato TJ.Blood-Brain barrier protection as a therapeutic strategy for acute ischemic stroke[J].AAPS J,2017,19(4):957-972.
[7] Yu S,Liebeskind DS,Dua S,et al.Postischemic hyperperfusion on arterial spin labeled perfusion MRI is linked to hemorrhagic transformation in stroke[J].J Cereb Blood Flow Metab,2015,35(4):630-637.
[8] Zhang J,Yang Y,Sun H,et al.Hemorrhagic transformation after cerebral infarction: current concepts and challenges[J]. Ann Transl Med,2014,2(8):81.
[9] Del Zoppo GJ,Mabuchi T.Cerebral microvessel responses to focal ischemia[J].J Cereb Blood Flow Metab,2003,23(8):879-894.
[10] Rosell A,Cuadrado E,Ortega-Aznar A,et al.MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke[J].Stroke,2008,39(4):1121-1126.
[11] Chen SY,Chen ZZ,Cui JK,et al.Early abrogation of gelatinase activity extends the time window for tPA thrombolysis after embolic focal cerebral ischemia in mice[J].Eneuro,2018,5(3):317-319.
[12] Inzitari D,Nencini P,Gori AM,et al.MAGIC study group MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death[J].Stroke,2013,44(10):2901-2903.
[13] Graham CA,Chan RW,Chan DY,et al.Matrix metalloproteinase 9 mRNA: An early prognostic marker for patients with acute stroke[J].Clin Biochem,2012,45(4/5):352-355.
[14] Demir R,Ulvi H,Ozel L,et al.Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke[J].Acta Neurol Belg,2012,112(4):351-356.
[15] Planas AM,Sole S,Justicia C.Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia[J].Neurobiology of Disease,2001,8(5):834-846.
[16] Kaplan RC,Smith NL,Zucker SA,et al.Matrix metalloproteinase-3(MMP3)and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke[J].Atherosclerosis,2008,201(1):130-137.
[17] Adibhatla RM,Hatcher JF.Tissue plasminogen activator(tPA)and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies[J].CNS Neurol Disord Drug Targets,2008,7(3):243-253.
[18] Pan J,Konstas AA,Bateman BA,et al.Reperfusion injury following cerebral ischemia: pathophysiology, Mr imaging, and potential therapies[J].Neuroradiology,2007,49(2):93-102.
[19] Stanimirovic D,Satoh K.Inflammatory mediators of cerebral endothelium:a role in ischemic brain inflammation[J].Brain Pathology,2010,10(1):113-126.
[20] Vivien D,Gauberti M,Guedin P,et al.Cerebral ischemia(2), How to neutralize the neurotoxic effects of tPA[J].Med Sci(Paris),2009,25(10):855-857.
[21] Zhang RL,Chopp M,Chen H,et al.Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient(2H)middle cerebral artery occlusion in the rat[J].Journal of the Neurological Sciences,1994,125(1):3-10.
[22] Bednar MM,Raymond S,McAuliffe T,et al.The role of neutrophils and platelets in a rabbit model of thromboembolic stroke[J].Stroke,1991,22(1):44-50.
[23] Yingqi,Xing,Zhen ZN,et al.Increased globulin and its association with hemorrhagic transformation in patients receiving intra-arterial thrombolysis therapy[J].Neurosci Bull,2014,30(3):469-476.
[24] Fabian RH,Dewitt DS,Kent TA.In vivo detection of superoxide anion production by the brain using a cytochrome electrode[J].J Cereb Blood Flow Metab,1995,15(2):242-247.
[25] Sanderson TH,Reynolds CA,Kumar R,et al.Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive Oxygen species Generation[J].Mol Neurobiol,2013,47(1):9-23.
[26] Lambeth JD.Lambeth,JD.NOX enzymes and the biology of reactive Oxygen.Nat Rev Immunol 4:181-189[J].Nat Rev Immunol,2004,4(3):181-189.
[27] Dominguez C,Delgado P,Vilches AA,et al.Oxidative stress after Thrombolysis-Induced reperfusion in human stroke[J].Stroke,2010,41(4):653-660.
[28] Khatri R,Mckinney AM,Swenson BA.Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke[J].Neurology,2012,79(13, 1):S52-S57.
[29] Li P,Hu X,Gan Y,et al.Mechanistic insight into DNA damage and repair in ischemic stroke:exploiting the base excision repair pathway as a model of neuroprotection[J].Antioxid Redox Signal,2011,14(10):1905-1918.
[30] Mallolas J,Rodríguez R,Gubern C,et al.A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke[J].Neuromolecular Med,2014,16(4):856-861.
[31] Lakhan SE,Kirchgessner A,Tepper D,et al.Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke[J].Front Neurol,2013,4:32.
[32] Foerch C,Wunderlich MT,Dvorak F,et al.Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke[J].Stroke,2007,38(9):2491-2495.